期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
A PRELIMINARY STUDY OF SERUM GLYCOCONIUGATES IN PATIENTS WITH CANCER USING THE ENZYME-LINKED LECTIN ASSAY
1
作者 张胜乐 梁伊仁 +2 位作者 李经略 戴奕然 黄迪 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 1990年第1期50-53,共4页
After primary analyses on the serum glycocon-jugates of lung cancer and normal individul using the enzyme-linked lectin assay (ELLA) with 12 kinds of lectins, PHA and LCA were selected to further study in the sera of ... After primary analyses on the serum glycocon-jugates of lung cancer and normal individul using the enzyme-linked lectin assay (ELLA) with 12 kinds of lectins, PHA and LCA were selected to further study in the sera of 8 kinds of cancers, 4 kinds of non-malignant disease and 1 kind of postoperative cancer. It was found that the test values of 7 kinds of cancers with PHA or LCA were significantly higher than that of the normal (P<0.01); the values of 4 kinds of non-malignant diseases with PHA were not higher (P>0.05); the values of the postoperative cancer with PHA were obviously lower than that of the preoperative (P<0.05). The results showed that the serum glycoconjugates which can bind to PHA seemed related to the cancerous existence in human bodies. The significance of the findings was discussed. 展开更多
关键词 than A PRELIMINARY STUDY OF SERUM GLYCOCONIUGATES IN patients with cancer USING THE ENZYME-LINKED LECTIN ASSAY LCA
下载PDF
Challenges of COVID-19 vaccination in patients with cancer 被引量:1
2
作者 Siyue Jia Wenbo Zhu +1 位作者 Hudachuan Jiang Fengcai Zhu 《National Science Open》 2022年第1期19-25,共7页
Patients with cancer are at increased risk of SARA-CoV-2 infection or developing severe COVID-19 cases due to malignancy or immunosuppressive therapy,but they are generally excluded from the target population for COVI... Patients with cancer are at increased risk of SARA-CoV-2 infection or developing severe COVID-19 cases due to malignancy or immunosuppressive therapy,but they are generally excluded from the target population for COVID-19 vaccination.In general,inactivated vaccines are safe and immunogenic for patients with cancer,but live attenuated vaccines are not recommended.The study suggested that the safety of the mRNA COVID-19 vaccine in patients with cancer is similar to that in healthy people,but immunogenicity is slightly weaker,and a booster dose may be needed.This paper aims to summarize the results of COVID-19 vaccine clinical studies conducted in patients with cancer worldwide and the relevant guidelines released by authorities,so as to provide evidence for promoting COVID-19 vaccination for patients with cancer. 展开更多
关键词 COVID-19 VACCINE clinical trial patients with cancer
原文传递
Clinical Communication, Cancer Patients &Considerations to Minimize the Challenges 被引量:1
3
作者 Irtiza Hasan Tasnuva Rashid 《Journal of Cancer Therapy》 2016年第2期107-113,共7页
Clinical communication is a multidimensional concept, which encompasses the core of effective clinical practice. Communication in cancer patients is particularly challenging and yet a less focused area in cancer care.... Clinical communication is a multidimensional concept, which encompasses the core of effective clinical practice. Communication in cancer patients is particularly challenging and yet a less focused area in cancer care. Various barriers and challenges in communication may affect the management protocol of cancer patients. Challenges may arise in various dimensions of cancer care including breaking bad news to delivery of complex clinical information, determination of appropriate treatment strategies, dealing with uncertainties, end of life counseling as well as cultural and language barriers affecting the whole communication dynamics. Effective communication is the basic foundation for responsive treatment decisions, positive health outcome, patient driven compliance and overall high quality of care. Thus, there is a need for acknowledging and actively deciphering the challenges and developing and promoting various protocols of effective communication skills in cancer patients. 展开更多
关键词 Physician-Patient Communication Communication with cancer patients Communication Challenges Patient-Centered Communication
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部